Pretreating mesenchymal stem cells with IL-6 regulates the inflammatory response of DSS-induced ulcerative colitis in rats

Transplant Immunology - Tập 76 - Trang 101765 - 2023
Quanhua Ding1,2,3, Hao Fang2, Peihua Jin2, Jianxin Lv2, Shaoqing Ding2, Weina Zhu4, Chunxiao Chen1
1Department of Gastroenterology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China
2Department of Gastroenterology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo 315000, Zhejiang Province, China
3Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo 315000, Zhejiang Province, China
4Department of Pharmacy, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo 315000, Zhejiang Province, China.

Tài liệu tham khảo

Magro, 2017, Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders, J. Crohns Colitis, 11, 649, 10.1093/ecco-jcc/jjx008

Baumgart, 2007, Inflammatory bowel disease: cause and immunobiology, Lancet, 369, 1627, 10.1016/S0140-6736(07)60750-8

Gajendran, 2019, A comprehensive review and update on ulcerative colitis, Disease-a-month, 65, 10.1016/j.disamonth.2019.02.004

Ananthakrishnan, 2015, Epidemiology and risk factors for IBD, Nat. Rev. Gastroenterol. Hepatol., 12, 205, 10.1038/nrgastro.2015.34

Ng, 2017, Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies, Lancet, 390, 2769, 10.1016/S0140-6736(17)32448-0

Alsoud, 2021, Breaking the therapeutic ceiling in drug development in ulcerative colitis, Lancet Gastroenterol. Hepatol., 6, 589, 10.1016/S2468-1253(21)00065-0

Triantafillidis, 2009, Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies, Anticancer Res., 29, 2727

Wakefield, 2018, Prescribing options for ulcerative colitis, Nurse Prescrib., 16, 9, 10.12968/npre.2018.16.Sup7.9

Bressler, 2015, Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus, Gastroenterology, 148, 1035, 10.1053/j.gastro.2015.03.001

Panaccione, 2019, Canadian Association of Gastroenterology clinical practice guideline for the management of luminal Crohn’s disease, J. Can. Assoc. Gastroenterol., 2, e1, 10.1093/jcag/gwz019

Pithadia, 2011, Treatment of inflammatory bowel disease (IBD), Pharmacol. Rep., 63, 629, 10.1016/S1734-1140(11)70575-8

Colombel, 2012, Therapeutic drug monitoring of biologics for inflammatory bowel disease, Inflamm. Bowel Dis., 18, 349, 10.1002/ibd.21831

Neurath, 2017, Current and emerging therapeutic targets for IBD, Nat. Rev. Gastroenterol. Hepatol., 14, 269, 10.1038/nrgastro.2016.208

Via, 2012, Biological properties of mesenchymal stem cells from different sources, Muscles Ligam. Tend. J., 2, 154

Ohishi, 2010, Bone marrow mesenchymal stem cells, J. Cell. Biochem., 109, 277, 10.1002/jcb.22399

Brown, 2019, Mesenchymal stem cells: cell therapy and regeneration potential, J. Tissue Eng. Regen. Med., 13, 1738, 10.1002/term.2914

González, 2009, Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses, Gastroenterology, 136, 978, 10.1053/j.gastro.2008.11.041

González, 2009, Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells, Arthritis Rheum., 60, 1006, 10.1002/art.24405

Németh, 2009, Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production, Nat. Med., 15, 42, 10.1038/nm.1905

Chamberlain, 2007, Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing, Stem Cells, 25, 2739, 10.1634/stemcells.2007-0197

Dazzi, 2006, The role of mesenchymal stem cells in haemopoiesis, Blood Rev., 20, 161, 10.1016/j.blre.2005.11.002

Belema-Bedada, 2008, Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2, Cell Stem Cell, 2, 566, 10.1016/j.stem.2008.03.003

Sato, 2007, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells, Blood, 109, 228, 10.1182/blood-2006-02-002246

Cho, 2017, Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner, Cell. Mol. Immunol., 14, 895, 10.1038/cmi.2016.59

Liu, 2015, Mesenchymal stem cells recruit macrophages to alleviate experimental colitis through TGFβ1, Cell. Physiol. Biochem., 35, 858, 10.1159/000369743

Tanaka, 2008, Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats, Life Sci., 83, 771, 10.1016/j.lfs.2008.09.016

Shi, 2019, Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis of experimental and clinical studies, Stem Cell Res Ther, 10, 1, 10.1186/s13287-019-1336-4

Hosseini-Asl, 2020, Therapeutic effect of mesenchymal stem cells in ulcerative colitis: a review on achievements and challenges, J. Clin. Med., 9, 3922, 10.3390/jcm9123922

Saparov, 2016, Preconditioning of human mesenchymal stem cells to enhance their regulation of the immune response, Stem Cells Int., 2016, 10.1155/2016/3924858

Wędrychowicz, 2018, Prognostic value of assessment of stool and serum IL-1β, IL-1ra and IL-6 concentrations in children with active and inactive ulcerative colitis, Arch. Med. Sci., 14, 107, 10.5114/aoms.2017.68696

Lee, 2012, Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis, PLoS One, 7

Mitsuyama, 1995, Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6, Gut, 36, 45, 10.1136/gut.36.1.45

Atreya, 2000, Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo, Nat. Med., 6, 583, 10.1038/75068

Neurath, 2001, Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question, Trends Immunol., 22, 21, 10.1016/S1471-4906(00)01798-1

Grivennikov, 2009, IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer, Cancer Cell, 15, 103, 10.1016/j.ccr.2009.01.001

Jin, 2010, Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice, Gut, 59, 186, 10.1136/gut.2008.151175

Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753

Zhang, 2009, Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis, J. Immunol., 183, 7787, 10.4049/jimmunol.0902318

Balzola, 2010, Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis: commentary, Inflamm. Bowel Disease Monit., 10, 103

Geboes, 2003, Histopathology of Crohn’s disease and ulcerative colitis, Inflamm. Bowel Dis., 4, 210

Hess, 2008, Stem cells and neurological diseases, Cell Prolif., 41, 94, 10.1111/j.1365-2184.2008.00486.x

Blau, 2019, Stem cells in the treatment of disease, N. Engl. J. Med., 380, 1748, 10.1056/NEJMra1716145

Newman, 2009, Treatment of inflammatory diseases with mesenchymal stem cells, Inflamm. Allergy-Drug Targ. (formerly Current Drug Targets-Inflammation & Allergy) (Discontinued), 8, 110

Uccelli, 2015, The immunomodulatory function of mesenchymal stem cells: mode of action and pathways, Ann. N. Y. Acad. Sci., 1351, 114, 10.1111/nyas.12815

Qu, 2018, Immunomodulatory function of mesenchymal stem cells: regulation and application, J. Cell. Immunother., 4, 1, 10.1016/j.jocit.2018.09.001

Zhou, 2019, The immunomodulatory functions of mesenchymal stromal/stem cells mediated via paracrine activity, J. Clin. Med., 8, 1025, 10.3390/jcm8071025

Shi, 2018, Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases, Nat. Rev. Nephrol., 14, 493, 10.1038/s41581-018-0023-5

Ren, 2008, Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide, Cell Stem Cell, 2, 141, 10.1016/j.stem.2007.11.014

Nauta, 2007, Immunomodulatory properties of mesenchymal stromal cells, blood, J. Am. Soc. Hematol., 110, 3499

Noone, 2013, IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro, Stem Cells Dev., 22, 3003, 10.1089/scd.2013.0028

François, 2012, Human MSC suppression correlates with cytokine induction of indoleamine 2, 3-dioxygenase and bystander M2 macrophage differentiation, Mol. Ther., 20, 187, 10.1038/mt.2011.189

Fan, 2012, Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis, Cell. Mol. Immunol., 9, 473, 10.1038/cmi.2012.40

Thông tin
Thông tin xuất bản

Transplant Immunology

Tập 76

101765

Thông tin tác giả